Real-world Treatment Patterns and Associated Outcomes in Patients With Resectable Early-stage Non-small Cell Lung Cancer

CompletedOBSERVATIONAL
Enrollment

748

Participants

Timeline

Start Date

November 3, 2021

Primary Completion Date

October 31, 2022

Study Completion Date

October 31, 2022

Conditions
Non-small Cell Lung Cancer
Trial Locations (25)

110005

Research Site, Delhi

110017

Research Site, New Delhi

121001

Research Site, Faridabad

400012

Research Site, Mumbai

400036

Research Site, Mumbai

400615

Research Site, Mumbai

560017

Research Site, Bangalore

700160

Research Site, Kolkata

711103

Research Site, Howrah, Kolkata

Unknown

Research Site, Sydney

Research Site, Brisbane

Research Site, Perth

Research Site, Alexandria

Research Site, Cairo

Research Site, Sohag

Research Site, Hong Kong

Research Site, Kuwait City

Research Site, Adana

Research Site, Ankara

Research Site, Antalya

Research Site, Diyarbakır

Research Site, Istanbul

Research Site, Izmir

Research Site, Samsun

Research Site, Alain

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY